TNF and colitis: Interestingly, despite the lack of clinical improvement of colitis by blocking of TNF from “non-T cells”, levels of IL-22BP were reduced upon infliximab administration (Fig. S11L), indicating that “non-T” cell derived TNF may also regulate IL-22BP production.